Cancer evolutionary modeling for precision medicine based therapeutics

来源 :第四届广州国际肿瘤学会议 | 被引量 : 0次 | 上传用户:caisilver
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
The origin of cancer is always described with a set of complicated reasons.Some scientists claim that cancer cells are the same as parasites.
其他文献
Introduction: Elevated c-FLIP levels which are observed in many cancers,were also shown to correlate with a more aggressive tumor.
Aberrant AKT activation is prevalent across multiple human cancer lineages,providing an important target for therapy.Phosphorylation plays critical roles in AKT stability and activation.
To investigate whether progression-free survival(PFS)can be considered a surrogate endpoint for overall survival(OS)in malignant mesothelioma both at the patient and trial level.
会议
Background Transcatheter arterial chemoembolization(TACE)is the first-line therapy for unresectable Hepatocellular Carcinoma(HCC),acute liver function deterioration(ALFD)after operation is a severe co
Objective: To evaluate efficacy and security of treatment by bevacizumab and platinum on advanced nonsmall-cell lung cancer.
Objective: Summary of the latest progress of bevacizumab combined with chemotherapy in the treatment of lung cancer in recent 4 years.
Objective: Research on the mechanism of bevacizumab combined with cisplatin inhibits the invasion and metastasis of Lewis lung adenocarcinoma.
OBJECTIVE: To observe efficacy and security of five chemotherapeutic schemes including platinum on advanced nonsmall-cell lung cancer.
The epithelial-mesenchymal transition(EMT)has been shown to induce cancer stem traits.However,pharma-therapeutic approach to simultaneously prevent EMT and cancer stemness is lacking.
The conventional strategy for cancer therapy offers limited control of specificity and efficacy,study on the molecular mechanism involved in tumor growth and angiogenesis provides novel targets and dr